Cascara sagrada (Rhamnus purshiana)
EMA-monograph stimulant laxative, same hydroxyanthracene class as senna, similar short-term-only positioning.
- Evidence
- Traditional useGRADE certainty: Very low
- Typical dose
- Dried bark: 20–30 mg hydroxyanthracene derivatives at bedtime
- Time to effect
- 8–12 hours after a single dose
- Safety
- Has documented cautions
Evidence ratings summarise published research on Cascara sagrada (Rhamnus purshiana) in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about Cascara sagrada (Rhamnus purshiana)
Interactions
Taking any medication?
Check Cascara sagrada (Rhamnus purshiana) against it.
Why
Cascara sagrada (Rhamnus purshiana) bark holds an EMA HMPC Traditional Use monograph for short-term relief of occasional constipation, based on long-standing use rather than trials. Hydroxyanthracene mechanism is essentially the same class as senna. EFSA has flagged hydroxyanthracene safety concerns (genotoxicity at high cumulative doses), limit to short courses; senna is the more commonly-prescribed European alternative.
How it works
Cascarosides are converted in the colon to active aglycones, which stimulate colonic motility and inhibit Na/K-ATPase in colonocytes, same mechanism as senna and aloe latex.
Expected onset · 8–12 hours after a single dose
How to take
Dosage
Dried bark: 20–30 mg hydroxyanthracene derivatives at bedtime (typically equivalent to 0.25–1 g dried bark). Maximum 1–2 weeks of continuous use.
Timing
Bedtime, effect 8–12 hours later
On the label
Aged cascara bark (at least 1 year stored, per EMA monograph) is required, fresh bark contains free anthrones causing severe cramping. EMA-registered preparations comply.
Studied in
Adults with short-term occasional constipation; not for chronic use.
Safety
Evidence
Registered by the EMA as a traditional herbal medicine for short-term relief of occasional constipation (long-standing use, not clinical trials). No randomised trials back this use. A 2018 EFSA review of hydroxyanthracene derivatives, the active compound class, identified genotoxicity concerns at high cumulative doses, which is why use is limited to the short term.
GRADE certainty: Very low — EMA traditional use (long-standing use, not trials)
Questions people ask
Does Cascara sagrada (Rhamnus purshiana) work?
Registered by the EMA as a traditional herbal medicine for short-term relief of occasional constipation (long-standing use, not clinical trials). No randomised trials back this use. A 2018 EFSA review of hydroxyanthracene derivatives, the active compound class, identified genotoxicity concerns at high cumulative doses, which is why use is limited to the short term. Certainty of the evidence: Very low, EMA traditional use (long-standing use, not trials).
How is Cascara sagrada (Rhamnus purshiana) taken?
Dried bark: 20–30 mg hydroxyanthracene derivatives at bedtime (typically equivalent to 0.25–1 g dried bark). Maximum 1–2 weeks of continuous use. Timing: Bedtime, effect 8–12 hours later. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
Hydroxyanthracene class. Chronic use causes hypokalaemia, melanosis coli, and is genotoxicity-flagged by EFSA. Avoid in intestinal obstruction, ileus, undiagnosed abdominal pain, severe dehydration, inflammatory bowel disease, children under 12, and pregnancy. Interactions with cardiac glycosides, antiarrhythmics, diuretics (potassium depletion). Limit to 1–2 weeks continuous use; no more than 5 episodes per year. Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: EMA HMPC monograph, Rhamnus purshianus DC. (syn. Frangula purshiana Cooper), cortex (Traditional Use).
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.